The increasing threat of new and re-emerging infectious diseases requires advanced solutions. Our global team at Clinicalae has accumulated over 200 years of combined experience in vaccine research and development. This deep expertise allows us to anticipate challenges and deliver high-quality results within budget, consistently beating startup timelines and enrollment goals.
Our team understands the urgency, complexities, and potential challenges of running vaccine trials. During the COVID-19 pandemic, we have been involved in over 130 COVID-19 trials, leveraging our extensive experience in prophylactic vaccine studies. Notably, we provided clinical trial services to the Pfizer and BioNTech SE investigational COVID-19 vaccine program.
By selecting Clinicalae as your contract research organization (CRO) partner, you benefit from: